Your browser is no longer supported. Please, upgrade your browser.
Settings
HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E14.19 EPS (ttm)5.27 Insider Own1.00% Shs Outstand258.61M Perf Week-0.90%
Market Cap19.35B Forward P/E14.62 EPS next Y5.12 Insider Trans-3.49% Shs Float255.98M Perf Month-6.16%
Income1.38B PEG1.36 EPS next Q2.57 Inst Own96.60% Short Float1.54% Perf Quarter7.64%
Sales4.54B P/S4.27 EPS this Y671.70% Inst Trans-0.12% Short Ratio1.99 Perf Half Y23.94%
Book/sh12.64 P/B5.92 EPS next Y-42.17% ROA19.50% Target Price89.08 Perf Year53.26%
Cash/sh3.36 P/C22.28 EPS next 5Y10.47% ROE53.70% 52W Range26.49 - 85.00 Perf YTD2.73%
Dividend- P/FCF14.09 EPS past 5Y56.10% ROI21.10% 52W High-11.98% Beta1.20
Dividend %- Quick Ratio2.10 Sales past 5Y6.90% Gross Margin65.60% 52W Low182.45% ATR2.91
Employees5814 Current Ratio2.50 Sales Q/Q89.30% Oper. Margin40.70% RSI (14)43.49 Volatility2.94% 3.54%
OptionableYes Debt/Eq0.85 EPS Q/Q74.60% Profit Margin30.50% Rel Volume0.75 Prev Close74.64
ShortableYes LT Debt/Eq0.83 EarningsJan 27 AMC Payout0.00% Avg Volume1.99M Price74.82
Recom1.80 SMA20-5.78% SMA50-2.99% SMA20012.01% Volume1,495,937 Change0.24%
Nov-20-20Downgrade Needham Buy → Hold
Nov-05-20Reiterated Needham Buy $78 → $88
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Aug-01-19Reiterated Needham Buy $52 → $57
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Jan-02-19Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18Initiated UBS Neutral
Sep-13-18Downgrade BofA/Merrill Buy → Neutral
Mar-02-21 11:40AM  
09:44AM  
07:14AM  
Mar-01-21 11:15AM  
11:11AM  
10:31AM  
09:51AM  
07:00AM  
Feb-26-21 10:16AM  
09:26AM  
09:22AM  
08:53AM  
Feb-25-21 04:01AM  
Feb-22-21 04:02PM  
Feb-19-21 05:30AM  
Feb-14-21 07:47AM  
Feb-12-21 11:47AM  
11:40AM  
10:38AM  
10:05AM  
09:19AM  
09:17AM  
08:58AM  
08:30AM  
Feb-11-21 08:49PM  
12:24PM  
11:47AM  
10:35AM  
09:55AM  
09:11AM  
08:22AM  
08:00AM  
Feb-10-21 04:05PM  
11:31AM  
11:11AM  
Feb-09-21 09:59AM  
09:13AM  
Feb-08-21 12:00PM  
07:00AM  
06:33AM  
Feb-05-21 09:50AM  
08:11AM  
07:40AM  
Feb-04-21 01:34PM  
08:08AM  
08:07AM  
03:12AM  
Feb-03-21 06:40PM  
10:30AM  
09:48AM  
08:45AM  
07:31AM  
Feb-02-21 03:43PM  
01:11PM  
09:39AM  
08:05AM  
Feb-01-21 04:01PM  
11:30AM  
10:36AM  
Jan-31-21 11:45PM  
Jan-29-21 08:33AM  
12:48AM  
Jan-28-21 01:01PM  
12:45PM  
12:10PM  
10:43AM  
10:40AM  
08:03AM  
Jan-27-21 08:31PM  
05:25PM  
04:44PM  
04:01PM  
02:30PM  
11:51AM  
11:40AM  
09:44AM  
Jan-26-21 10:00AM  
Jan-25-21 09:47AM  
Jan-22-21 09:51AM  
09:28AM  
08:04AM  
Jan-21-21 02:42PM  
Jan-20-21 05:50PM  
11:36AM  
09:01AM  
06:18AM  
Jan-19-21 09:52AM  
09:16AM  
09:00AM  
Jan-18-21 10:05AM  
09:49AM  
09:41AM  
08:41AM  
Jan-15-21 10:25AM  
08:35AM  
Jan-14-21 05:50PM  
05:41PM  
12:16PM  
11:51AM  
11:30AM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bebo Allison PSVP, Human ResourcesFeb 05Sale84.066,100512,77835,680Feb 09 04:18 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Option Exercise39.968,396335,50425,048Feb 08 04:56 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Sale84.318,396707,86716,652Feb 08 04:56 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Option Exercise38.6916,869652,65842,452Dec 14 04:44 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 10Sale73.641,477108,75916,575Dec 14 04:41 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Sale73.9916,8691,248,21233,216Dec 14 04:44 PM
Griffin John M.General CounselNov 18Option Exercise39.9622,900915,084157,386Nov 20 04:12 PM
Griffin John M.General CounselNov 18Sale71.0822,9001,627,689134,486Nov 20 04:12 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Option Exercise26.215,000131,05023,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Sale72.585,000362,90018,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Option Exercise26.216,542171,46625,127Nov 16 04:24 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Sale70.606,542461,84618,585Nov 16 04:24 PM
GARRETT SCOTT TDirectorNov 09Option Exercise22.3511,146249,11362,531Nov 12 04:26 PM
Stamoulis ChristianaDirectorNov 04Option Exercise22.3511,146249,11350,538Nov 06 04:10 PM
Stamoulis ChristianaDirectorNov 04Sale74.0011,146824,80439,392Nov 06 04:10 PM
Oberton Karleen MarieChief Financial OfficerSep 22Option Exercise26.215,461143,13334,417Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Option Exercise26.2115,000393,15043,956Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Sale62.5015,000937,50028,956Sep 23 04:21 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Option Exercise23.822,98671,12719,699Aug 05 05:49 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Sale71.244,924350,81016,713Aug 05 05:49 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Option Exercise26.2110,493275,02270,484Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Sale54.0710,493567,35759,991Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Option Exercise26.2110,493275,02270,484May 27 04:12 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Sale51.8210,493543,77959,991May 27 04:12 PM
CRAWFORD SALLYDirectorMay 22Sale51.9931,9501,661,081126,847May 27 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Option Exercise26.0113,888361,22730,914May 19 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Sale51.5113,888715,42617,026May 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Option Exercise22.29215,9964,814,5511,913,438May 15 04:17 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Sale50.97190,9969,735,2571,722,442May 15 04:17 PM
GARRETT SCOTT TDirectorMay 01Option Exercise20.3424,204492,30951,385May 05 04:16 PM
Griffin John M.General CounselApr 28Option Exercise32.384,906158,85698,080Apr 30 04:07 PM
Griffin John M.General CounselApr 28Sale50.004,906245,30095,307Apr 30 04:07 PM
CRAWFORD SALLYDirectorMar 09Option Exercise22.3511,146249,113169,943Mar 11 04:07 PM
CRAWFORD SALLYDirectorMar 09Sale44.0811,146491,317158,797Mar 11 04:07 PM